When the ATG16L1 gene is missing or mutated in IBD patients, the autophagy of the patient’s organism will be disrupted, while the autophagy level of the cells will be significantly reduced, and it is even impossible to form autophagosomes. This evidence concerns the gene ATG16L1 and inflammatory bowel disease.